The Texas Heart Institute is recognized internationally for research programs in cardiology, cardiovascular surgery, regenerative medicine and pathology. Our physicians and scientists conduct research ranging from gene therapy, stem cells and regenerative medicine, to wireless and battery-less pacemakers, ventricular assist devices (VADs) and artificial hearts.
In the spring of 2018, Dr. Emerson Perin was appointed by the THI Board of Trustees to serve as the new Medical Director and is already making tremendous progress toward positioning THI for unparalleled growth.
Newly launched in early 2018, Texas Heart Institute’s (THI) Center for Clinical Research (CCR) supports all areas of cardiovascular clinical research, from protocol development to trial facilitation and post-trial assessment and reporting.
Research By The Numbers
THI’s initiative to address women’s health issues was launched nearly 10 years ago with the support of community leaders. Led by Dr. Stephanie Coulter, the Women’s Center is addressing significant gaps in the care of women suffering from or at risk for developing heart and vascular disease.
Texas Heart Institute (THI) doctors and engineers are committed to developing new pacing devices that will eliminate the need for batteries and wires and, more importantly, reduce the pain of the electrical shocks delivered by an implantable cardiac defibrillator.
One of the unique strengths of THI resides in the ability of its professional staff to perform surgical and interventional preclinical research. The preclinical research laboratory at THI reflects the high standard of excellence established by Dr. Cooley and Dr. Frazier over the last five decades.
Enthusiasm for the potential of regenerative medicine has resonated with patients and families around the world since the 1990s. Several local, state, and national partnerships have made possible new discoveries.
THI researchers and their collaborators are conducting groundbreaking work that is taking us one step closer to heart regeneration and renewal.
THI's molecular cardiology research benefits from an unparalleled leadership team with a strong track record of making significant discoveries in the use of small molecules for diagnostic and therapeutic medicine and shepherding these discoveries along the drug development track.